Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Crinetics Pharmaceuticals, Inc. - Common Stock (NQ:CRNX)

84.80 +0.02 (+0.02%)

Streaming Delayed Price Updated: 3:51 PM EDT, Aug 25, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,041,807
Open	84.83
Bid (Size)	84.79 (3,600)
Ask (Size)	84.80 (1,500)
Prev. Close	84.78
Today's Range	84.78 - 84.84
52wk Range	29.91 - 84.81
Shares Outstanding	54,026,103
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX

August 17, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More ↗

August 14, 2026

The drugmaker should significantly mitigate its most important risk as it develops new products.

Via The Motley Fool

Performance

YTD	+81.5%	+81.5%
1 Month	+1.1%	+1.1%
3 Month	+130.5%	+130.5%
6 Month	+93.6%	+93.6%
1 Year	+181.8%	+181.8%

More News

Halper Sadeh LLC is Investigating Whether BZH, ACA, SYNA, CRNX are Obtaining Fair Deals for their Shareholders

August 08, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire? ↗

August 07, 2026

Via The Motley Fool

Why Vertex Pharmaceuticals Stock Ticked Higher on Tuesday ↗

August 04, 2026

Via The Motley Fool

Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

August 03, 2026

From Crinetics Pharmaceuticals, Inc.

Via GlobeNewswire

Vertex Just Paid $10 Billion for Crinetics. Here's Why Viking Therapeutics Could Be the Next Big Pharma Takeover Target ↗

July 30, 2026

Via The Motley Fool

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TriCo Bancshares (Nasdaq – TCBK), Twin Vee PowerCats Co. (Nasdaq -VEEE), Crinetics Pharmaceuticals, Inc. (Nasdaq – CRNX), Element Solutions Inc. (NYSE – ESI)

July 21, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Shareholder Alert: Ademi LLP investigates whether Crinetics Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders

July 21, 2026

From Ademi LLP

Via GlobeNewswire

Vertex Pharmaceuticals Just Made a $10 Billion Acquisition Worth Watching ↗

July 19, 2026

Via The Motley Fool

Halper Sadeh LLC is Investigating Whether TCBK, ESI, CRNX, SOLS are Obtaining Fair Deals for their Shareholders

July 16, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether ESI, CRNX, SOLS are Obtaining Fair Deals for their Shareholders

July 15, 2026

From Halper Sadeh LLC

Via GlobeNewswire

July 14, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Here's Why Vertex Was Willing to Pay a Premium of More Than 100% for Crinetics Pharmaceuticals ↗

July 14, 2026

Via The Motley Fool

Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy? ↗

July 13, 2026

Via The Motley Fool

Is This Biotech Stock a Buy Near Its 52-Week High? ↗

July 10, 2026

Via The Motley Fool

Why This Pharmaceutical Stock Jumped Close to 100% This Week ↗

July 10, 2026

Via The Motley Fool

Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy? ↗

July 10, 2026

Via The Motley Fool

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

July 09, 2026

Via Chartmill

Here's How Much $1000 Invested In Crinetics Pharmaceuticals 5 Years Ago Would Be Worth Today ↗

July 08, 2026

Via Benzinga

Halper Sadeh LLC is Investigating Whether CRNX, ESI, INVE, SLP are Obtaining Fair Deals for their Shareholders

July 08, 2026

From Halper Sadeh LLC

Via GlobeNewswire

The trading volume of these stocks is deviating from the norm in today's session. ↗

July 08, 2026

Via Chartmill

Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX

July 08, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Vertex’s Crinetics Deal Balances Growth with Integration Risk ↗

July 08, 2026

Via MarketBeat

Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It. ↗

July 08, 2026

Via The Motley Fool

Frequently Asked Questions

Is Crinetics Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Crinetics Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Crinetics Pharmaceuticals, Inc. - Common Stock trade on?

Crinetics Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Crinetics Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Crinetics Pharmaceuticals, Inc. - Common Stock is CRNX on the Nasdaq Stock Market

What is the current price of Crinetics Pharmaceuticals, Inc. - Common Stock?

The current price of Crinetics Pharmaceuticals, Inc. - Common Stock is 84.80

When was Crinetics Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Crinetics Pharmaceuticals, Inc. - Common Stock was at 08/25/26 03:51 PM ET

What is the market capitalization of Crinetics Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Crinetics Pharmaceuticals, Inc. - Common Stock is 4.58B

How many shares of Crinetics Pharmaceuticals, Inc. - Common Stock are outstanding?

Crinetics Pharmaceuticals, Inc. - Common Stock has 5B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.